Nanoemulsion Market Size, Share, And Growth Report 2032

Nanoemulsion Market: Size

The global Nanoemulsion Market size was worth around USD 11.86 billion in 2023 and is predicted to grow to around USD 22.36 billion by 2032 with a compound annual growth rate (CAGR) of roughly 7.3% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD billion). The report covers a forecast and an analysis of the Nanoemulsion Market on a global and regional level.

Request Free Sample

Nanoemulsion Market: Overview

Nanoemulsion is the novel drug delivery system or targeted drug delivery system that consists of water and emulsified oil with an average droplet diameter ranging from 50 to 1000 nm. Water in oil and oil in water are the two types of emulsion phases, which depends on the core particle that is either water or oil. The nanoemulsion-based drugs provide increased bioavailability of the drug molecule by providing target specific drug delivery. The nanoemulsion technique is used for drugs or active pharmaceutical ingredients whose solubility is low to poor. The nanoemulsions have good capacity to dissolve low soluble drugs and protect the drugs from enzymatic degradation or hydrolysis.

The major advantages of nanoemulsions as drug delivery carriers include improved drug loading, enhanced bioavailability and drug solubility, controlled drug release, and reduced patient variability and protection from enzymatic degradation. This is the major factor driving the global nanoemulsion market. Nanoemulsions have extensive applications in different fields like food technology, pharmaceutics, and cosmetics. The pharmaceutical application of nanoemulsions includes the various routes of administration, which is another factor supporting this global market’s growth. Recently, nanoemulsions are commonly used for delivery of DNA-encoded drug, vaccine, antibiotics, and topical preparations, which, in turn, will generate new growth opportunities for the nanoemulsion market globally in the future.

Request Free Sample

Nanoemulsion Market: Segmentation

The study provides a decisive view of the nanoemulsion market by segmenting it based on drug class, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on drug class, the global nanoemulsion market includes anesthetics, steroids, NSAIDs, immunosuppressant, antimicrobials, antiretroviral, vasodilators, and others. NSAIDs are expected to register notable growth in the future, owing to the increasing NSAIDs usage for various applications.

By route of administration, the global nanoemulsion market includes topical, parenteral, oral, and nasal.

By distribution channel, the global nanoemulsion market includes retail pharmacy, hospital pharmacy, and online pharmacy. Retail pharmacies are estimated to dominate the global nanoemulsion market over the estimated time period.

Nanoemulsion Market: Report Scope

Nanoemulsion Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Southeast Asia, Brazil, and Mexico.

By region, North America is expected to dominate the global nanoemulsion market over the forecast time period. Well-established biotechnology and pharmaceutical and industries, rising number of research activities for new drug development, increasing prevalence of chronic disorders, growing technological advancements in drug delivery techniques across the region are expected to boost the North American nanoemulsion market in the years ahead. Asia Pacific nanoemulsion market is projected to grow at the highest rate during the projected time period, owing to the increasing income of people and altering regional demographics.

Nanoemulsion Market: Competitive Players

Some major players operating in the global nanoemulsion market are:

• Mitsubishi Tanabe Pharma
• AbbVie
• Allergan
• Fresenius Kabi
• AstraZeneca
• GlaxoSmithKline
• Kaken Pharmaceutical
• Sanofi
• Novartis
• B. Braun Melsungen

The Global Nanoemulsion Market is segmented as follows:

Global Nanoemulsion Market: Drug Class Analysis

• Anesthetics
• Steroids
• NSAIDs
• Immunosuppressant
• Antimicrobials
• Antiretroviral
• Vasodilators
• Others

Global Nanoemulsion Market: Route of Administration Analysis

• Topical
• Parenteral
• Oral
• Nasal

Global Nanoemulsion Market: Distribution Channel Analysis

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Global Nanoemulsion Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa